$INMB CTAD (Clinical Trials on Alzheimer's Disease) conference coming up in Boston in mid-November. INmune shows up in here in a few places. Most notably, CJ presents on Friday morning in this presentation... 9.55 a.m LB12 - The Early Mild Alzheimer’s Cognitive Composite (EMACC): a meaningful primary cognitive endpoint in a phase 2 trial of XPro1595 in Alzheimer’s Disease (AD) with inflammation (ADi) Judith Jaeger 1, Melanie Buitendyk 2 , Christopher J. Barnum 3 1 Cognitionmetrics And Albert Einstein Col Of Medicine - Stamford Ct And Bronx Ny (United States), 2 Cato-Sms -Wilmington, Nc (United States), 3 Inmunebio - Boca Raton, Fl (United States) There are also several poster presentations. Here's a link to the conference. ctad-alzheimer.com/ And, if you want to download the program... ctad-alzheimer.com/files/fi...
CTAD Alzheimer Congress | 13th Clinical Trials on Alzheimer's Diseasevia: Ctad-alzheimer